# Sanjivani Paranteral Ltd (SANJIVIN)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹139.05
Day Change: -9.07%
52W High: ₹268.8
52W Low: ₹128
Market Cap: ₹167 Cr

## Valuation
P/E: 20.65
P/B: 3.75
EPS: ₹6.6
Book Value: ₹36.39
Dividend Yield: 37%

## Returns
1Y Return: -40.67%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Sanjivani Paranteral Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Sanjivani Paranteral Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Data Freshness
Quote Updated: 2026-05-21T06:00:24.951Z
Price History Updated: 2026-05-21T06:00:25.442Z
Latest Price History Date: 2026-05-21
Technicals Updated: 2026-05-21T06:00:25.442Z
Quant Updated: 2026-05-21T06:00:25.442Z
Sentiment Updated: 2026-05-21T06:00:25.442Z
Financials Status: current
Financials Updated: 2026-05-18T12:30:01.148Z
Financials Last Attempt: 2026-05-18T12:30:01.148Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2025)
Revenue: ₹54.41 Cr
Operating Profit: ₹8.23 Cr (OPM 15.13%)
Net Profit: ₹6.17 Cr
Tax: ₹7.57 Cr

## Annual P&L History
Mar 2025: Rev ₹54.41Cr | PAT ₹6.17Cr | OPM 15.13%
Mar 2026: Rev ₹70.1Cr | PAT ₹8.09Cr | OPM 14.75%

## Balance Sheet (Mar 2025)
Total Assets: ₹43.4 Cr
Total Liabilities: ₹43.4 Cr
Borrowings: ₹0.97 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/sanjivin
Disclaimer: For research and education only. Not investment advice.